Indication
Asthma
The Asthma pipeline: 92 tracked drugs, 38 approved for this indication.
38 approved / phase 421 Phase 31 Phase 2/319 Phase 21 Phase 1/29 Phase 13 preclinical / unstaged
Compare the share prices of listed companies in Asthma →
Total attributable cost
$107.9B
$4,333/patient
Drug spend
$45.6B
$1,830/patient
42% of total cost is drugs
All severities, current asthma (2021 estimate) · US